2-Fluoro-5-formylbenzoic acid

We are 2-Fluoro-5-formylbenzoic acid CAS:550363-85-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-Fluoro-5-formylbenzoic acid
CAS.NO: 550363-85-4
Synonyms:
fluoroformylbenzoicacid
2-fluoranyl-5-methanoyl-benzoic acid
2-fluoro-5-formyl-benzoic acid

Molecular Formula:C8H5FO3
Molecular Weight: 168.12200

Physical and Chemical Properties:
Density: 1.427g / cm3
Boiling point: 330.902ºC at 760 mmHg
Melting point: 174.5-178.5ºC
Flash point: 153.924ºC
Refractive index: 1.591

Specification:
Appearance:Pale brown solid
Purity:≥98%
Impurity: ≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Olaparib  CAS:763113-22-0

Related News: Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.2- (2-metilfenil) -2-oxoacetato de metilo CAS:34966-54-6 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.4-Methylbenzyl Bromide Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Methyl 4-methoxyacetoacetate The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.